Close
Smartlab Europe
Inizio Ignite

Elsevier integrates Reaxys with electronic laboratory notebook

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Injectable Drug Formulation Trends in Biopharma

Analysis of the evolving landscape of parenteral delivery, focusing on the stability of high-concentration biologics and the integration of patient-centric delivery devices.

Future Trends in Pharmaceutical Drug Delivery Platforms

Forward-looking perspective on the convergence of digital technology, bioengineering, and material science in creating the next generation of therapeutic delivery systems.

Advancing Drug Formulation Stability in Modern Pharma

Exploration of the chemical, physical, and environmental factors that compromise the integrity of modern therapeutics, and the advanced testing protocols used to ensure safety.
- Advertisement -

PerkinElmer has integrated its electronic laboratory notebook (ELN) with Elsevier’s Reaxys, a web-based workflow solution designed for chemistry researchers in drug discovery, chemicals and academic research.

PerkinElmer Informatics general manager Michael Stapleton said as chemists are turning to electronic laboratory notebooks to plan, execute and record their experiments, they also need ready access to complementary tools and data sources directly within the ELN interface.

“The interoperability of our ELN and Elsevier’s Reaxys provides researchers with access to extensive information on chemical compounds and related physical and pharmacological properties so that they can make better decisions,” Stapleton added.

”This integration also allows researchers to save valuable time by providing the ability to rapidly search and import external data while eliminating transcription errors.”

The new integrated solution enables access to reaction and substance data directly from Reaxys into the ELN for enhanced productivity and streamlined workflows.

The chemical searches in Reaxys can be initiated in an experimental section in the ELN based on existing or newly drawn compounds or reactions and results are made immediately available.

PerkinElmer provides discovery, collaboration and knowledge enterprise solutions, desktop software, scientific databases and consulting services to the pharmaceutical, biotechnology, and chemical industries.

Latest stories

Related stories

Injectable Drug Formulation Trends in Biopharma

Analysis of the evolving landscape of parenteral delivery, focusing on the stability of high-concentration biologics and the integration of patient-centric delivery devices.

Future Trends in Pharmaceutical Drug Delivery Platforms

Forward-looking perspective on the convergence of digital technology, bioengineering, and material science in creating the next generation of therapeutic delivery systems.

Advancing Drug Formulation Stability in Modern Pharma

Exploration of the chemical, physical, and environmental factors that compromise the integrity of modern therapeutics, and the advanced testing protocols used to ensure safety.

Drug Delivery Innovations Supporting Personalized Medicine

Investigation into the technological advancements that enable individualized therapeutic regimens, focusing on precision dosing, genetic tailoring, and smart delivery systems.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »